← Back to Search

Pulmonary Rehabilitation for Liver Disease

N/A
Recruiting
Led By Kymberly D Watt
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Wait listed for liver transplantation with poor 6 MWT
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3 months
Awards & highlights

Study Summary

This trial will test the effects of exercise on sarcopenia and frailty.

Who is the study for?
This trial is for adults on the liver transplant waiting list who have poor performance on a walking test (6 MWT). It's not suitable for those with severe heart, lung, or kidney diseases, recent heavy alcohol use, recent hospitalizations due to liver complications, certain esophageal issues without treatment, uncontrolled brain-liver connection problems (hepatic encephalopathy), specific lung-heart related liver conditions, or inability to exercise.Check my eligibility
What is being tested?
The study is testing two types of exercises: pulmonary rehabilitation and a home-based video strengthening program. The goal is to see how these exercises affect muscle wasting and weakness in people with end-stage liver disease awaiting transplantation.See study design
What are the potential side effects?
While the trial does not involve medication and focuses on exercise programs which are generally safe; fatigue, muscle soreness or injury could occur. Participants with advanced liver disease may also be at risk of exacerbating their condition if they overexert themselves.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am on the liver transplant list and have a poor walking test result.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in 6 minute walk test

Trial Design

2Treatment groups
Active Control
Group I: Home based programActive Control1 Intervention
Participants will participate in a Home based Exercise program
Group II: Pulmonary RehabilitationActive Control1 Intervention
Participants will participate in formal Pulmonary Rehabilitation Exercise program

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,213 Previous Clinical Trials
3,766,961 Total Patients Enrolled
Kymberly D WattPrincipal InvestigatorMayo Clinic
1 Previous Clinical Trials
19 Total Patients Enrolled

Media Library

Home Based Exercise Clinical Trial Eligibility Overview. Trial Name: NCT03266575 — N/A
Liver Disease Research Study Groups: Home based program, Pulmonary Rehabilitation
Liver Disease Clinical Trial 2023: Home Based Exercise Highlights & Side Effects. Trial Name: NCT03266575 — N/A
Home Based Exercise 2023 Treatment Timeline for Medical Study. Trial Name: NCT03266575 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the magnitude of individuals registered for this clinical experiment?

"Affirmative. According to information found on clinicaltrials.gov, this trial has been actively looking for participants since February 1st 2018 and was last updated on November 24th 2022 - the researchers are aiming to recruit 50 candidates from 2 different medical sites."

Answered by AI

Does the public have access to this research opportunity at present?

"That is correct. Clinicaltrials.gov reflects that this clinical trial, which was first published on February 1st 2018, is actively recruiting patients for participation. The study requires 50 participants to be enrolled from two distinct sites."

Answered by AI
~15 spots leftby Dec 2026